CClinicalTrials.gg
CompletedNCT03770143Updated Apr 23, 2019

Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance

An observational study in Feeding; Disorder, Nonorganic Origin, Calcium Disorder and Intestinal Bacteria Flora Disturbance, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged Up to 3 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-23.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
90
Ages
Up to 3 Months
Sex
All
01

Study summary

Depending on recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas. Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps. So it is suggested that intestinal flora might be affected as a reason of these specialties. This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.

Read the detailed description

Recent studies in literature the investigators aimed to compare whether gastrointestinal tolerance differs between infants fed with palm olein containing or palm olein free formulas. Besides it is showed that palm olein containing formulas decreases the absorption of fat and calcium by forming insoluble calcium soaps. So it is suggested that intestinal flora might be affected as a reason of these specialties. This study also aimed to investigate with culture-independent methods whether feeding infants with palm olein free formula results in the modification of their intestinal microbiota in such a way that is similar to breastfed ones.

02

Conditions studied

  • Feeding; Disorder, Nonorganic Origin
  • Calcium Disorder
  • Intestinal Bacteria Flora Disturbance

Browse trials for

03

In context

Dysbiosis

186 studies on the registry are indexed under Dysbiosis; 59 are open to participants now.

This study's enrollment of 90 is close to the median of 86 across 48 observational studies indexed under Dysbiosis.

Browse Dysbiosis studies →

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 216 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 3 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

A total of 90 healthy infants (30 under breast-feeding, 30 feeding with palm olein free formula and 30 feeding with palm olein formula) will be included. Infants feeding enterally more than %70 with breast milk will be considered as breast-feeding. Infants who had not adequate weight gain and need formula will be randomized to receive either palm olein or palm olein free term formula in addition to mother milk. Parental informed consent will be taken and infants whose parents give permission will be included.

Inclusion criteria

The data of the patients who fulfilled the following criteria are evaluated.

  1. Term infants between 38 and 40 weeks of gestational age and/or with a birth weight of > 2500grams who are either breastfed or formula fed.

    Selection of the subgroup using oral nutrition

  2. Feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life
  3. Feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life Selection of the subgroup not using oral nutritional supplement (control group)
  4. Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)

Exclusion criteria

Exclusion Criteria:

  • Infants with major congenital abnormalities will be excluded.
  • Infants with lack of data will also be excluded.
  • Infants, whose parents don't agree with informed consent, will be excluded.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
90 participants (actual)
Patient registry
No

Groups and cohorts

  • Group 1

    Infants feeding predominantly with palm olein free formula if presence in addition to breast milk for 8 weeks of life

    Other: Feeding with palm olein formula

  • Group 2

    Infants feeding with other formulas including palm olein if presence in addition to breast milk for 8 weeks of life

  • Group 3

    Having similar demographical properties with infants feeding with breast milk (gender, age, weight, height)

Interventions

  • OtherFeeding with palm olein formula
06

What researchers measure

Primary outcomes

  1. Stool consistency

    Amsterdam Infant Stool Scale

    Time frame: 10 weeks

Secondary outcomes

  1. Bacteria Count

    number of the copy of DNA of Intestinal Flora Content

    Time frame: 10 weeks

07

Study locations

1 site
  • Kanuni Sultan Suleyman Training and Research Hospital
    Istanbul, Kucukcekmece 34303, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03770143
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Responsible party
Merih Cetinkaya (Associate Professor, MD,PhD, Kanuni Sultan Suleyman Training and Research Hospital) — Principal investigator
First posted
Dec 10, 2018
Start date
May 2016
Primary completion
Aug 2016
Completion
Oct 2016
Last update
Apr 23, 2019

Study contacts

Seda Yilmaz Semerci
study director · Kanuni SSTRH
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion